Schrödinger makes significant investments in R&D, which has led to breakthroughs in quantum chemistry, molecular modeling, force fields, molecular dynamics, protein structure determination, scoring, and virtual screening.

The company's full product offerings range from general molecular modeling programs to a comprehensive suite of drug design software, as well as a state-of-the-art suite for materials research. Schrödinger is developing enterprise level software that can be deployed throughout an entire research organization. Schrödinger is committed to unparalleled product development and support.

Founded in 1990, Schrödinger has operations in several locations within the United States as well as in Europe, India, and Japan.